Accordingly, hepatocyte-specific deletion of JNK1/2 protects obese mice from hepatic steatosis, enlarges mitochondria (phenocopying Mfn2 gain of function), and elevates mitochondrial fatty acid oxidation via transcriptional upregulation of mitochondrial proteins [30]. Here, MFN2 is linked to fatty liver disease.